Skip to Content

Join the 'Myeloproliferative Disorders' group to help and get support from people like you.

Myeloproliferative Disorders News

FDA Approves Jakafi to Treat Myelofibrosis

Posted 17 Nov 2011 by

November 16, 2011 – The U.S. Food and Drug Administration today approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis. Myelofibrosis is a disease in which the bone marrow is replaced by scar tissue resulting in blood cells being made in organs such as the liver and the spleen. This disease is marked by an enlarged ...

Experimental Drug Fights Bone Marrow Cancers

Posted 9 Dec 2008 by

TUESDAY, Dec. 9 – An experimental drug called CYT387 blocks an enzyme that causes bone marrow cancers called myeloproliferative disorders (MPDs), according to U.S. researchers who conducted tests in mice and human cells. The findings were to be presented Tuesday at the annual meeting of the American Society of Hematology, in San Francisco. The researchers, from Oregon Health & Science ...

Ask a Question

Further Information

Related Condition Support Groups

Multiple Myeloma, Thrombocythemia, Polycythemia, Bone Marrow Depression / Low Blood Counts, Myelofibrosis, Myelodysplastic Diseases, Blood Disorders

Related Drug Support Groups

Gleevec, imatinib, ruxolitinib, Jakafi